Novo Nordisk reported 38.28B in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
Bausch Health Companies USD 912M 315M Jun/2025
Bristol-Myers Squibb USD 3.27B 1.63B Jun/2025
Eli Lilly USD 7.5B 3.34B Jun/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
Merck USD 7.74B 625M Mar/2025
Novartis USD 6.17B 339M Jun/2025
Novo Nordisk 38.28B 4.34B Jun/2025
Novo Nordisk DKK 46.05B 10.07B Mar/2025
Pacira USD 54.32M 24.98M Jun/2025
Sanofi EUR 1.89B 971M Jun/2025
Supernus Pharmaceuticals USD 41.47M 23.68M Jun/2025